Biopharma Business

Tag "Merck Sharp & Dohme"

MSD probed by UK for blocking Remicade biosimilars

    MSD probed by UK for blocking Remicade biosimilars

The UK government says Merck Sharp & Dohme (MSD) broke competition laws by lowering the price of its Remicade drug as biosimilar rivals came to market. The Competition and Markets

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements